{
    "root": "2ffd668f-69df-6eb8-e063-6394a90a04c3",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Cephalexin",
    "value": "20250310",
    "ingredients": [
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "CEPHALEXIN",
            "code": "OBN7UDS42Y"
        }
    ],
    "indications": "cephalexin cephalosporin antibacterial indicated treatment following infections caused susceptible isolates designated bacteria : respiratory tract infection ( 1.1 ) otitis media ( 1.2 ) skin skin structure infections ( 1.3 ) bone infections ( 1.4 ) genitourinary tract infections ( 1.5 ) reduce development drug-resistant bacteria maintain effectiveness cephalexin antibacterial drugs , cephalexin used treat infections proven strongly suspected caused bacteria . ( 1.6 )",
    "contraindications": "adults patients least 15 years age usual dose 250 mg every 6 hours , dose 500 mg every 12 hours may administered ( 2.1 ) pediatric patients ( 1 year age ) otitis media : 75 100 mg/kg equally divided doses every 6 hours ( 2.2 ) : 25 50 mg/kg given equally divided doses ( 2.2 ) severe infections : 50 100 mg/kg may administered equally divided doses ( 2.2 ) duration therapy ranges 7 to14 days depending infection type severity . ( 2 ) adjustment required patients severe end stage renal disease ( esrd ) defined creatinine clearance 30 ml/min . ( 2.3 )",
    "warningsAndPrecautions": "cephalexin capsules , usp , supplied follows : 250 mg capsules white white powder filled size 2 capsules ( dark green cap dark green body ) imprinted “ 220 ” cap body edible black ink . available follows : ndc : 70518-2273-00 ndc : 70518-2273-01 ndc : 70518-2273-02 ndc : 70518-2273-03 ndc : 70518-2273-04 packaging : 30 1 blister pack packaging : 14 1 blister pack packaging : 30 1 bottle plastic packaging : 28 1 bottle plastic packaging : 40 1 bottle plastic store 20°c 25°c ( 68°f to77°f ) ; excursions permitted 15 30°c ( 59 86°f ) [ usp controlled room temperature ] . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "cephalexin contraindicated patients known hypersensitivity cephalexin members cephalosporin class antibacterial drugs .",
    "indications_original": "Cephalexin is a cephalosporin antibacterial drug indicated for the treatment of the following infections caused by susceptible isolates of designated bacteria: Respiratory tract infection ( 1.1 ) Otitis media  ( 1.2 ) Skin and skin structure infections  ( 1.3 ) Bone infections (1.4) Genitourinary tract infections ( 1.5 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin and other antibacterial drugs, Cephalexin should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. (1.6)",
    "contraindications_original": "Adults and patients at least 15 years of age The usual dose is 250 mg every 6 hours, but a dose of 500 mg every 12 hours may be administered ( 2.1 ) Pediatric patients (over 1 year of age) Otitis media: 75 to 100 mg/kg in equally divided doses every 6 hours ( 2.2 ) All other indications: 25 to 50 mg/kg given in equally divided doses ( 2.2 ) In severe infections: 50 to 100 mg/kg may be administered in equally divided doses ( 2.2 ) Duration of therapy ranges from 7 to14 days depending on the infection type and severity. ( 2 ) Dosage adjustment is required in patients with severe and end stage renal disease (ESRD) defined as creatinine clearance below 30 mL/min. ( 2.3 )",
    "warningsAndPrecautions_original": "Cephalexin capsules, USP, are supplied as follows:\n                  The 250 mg capsules are a white to off white powder filled into size 2 capsules (dark green cap and dark green body) that are imprinted with “220” on the both cap and body in edible black ink. They are available as follows:\n                  NDC: 70518-2273-00\n                  NDC: 70518-2273-01\n                  \n                  NDC: 70518-2273-02\n  \nNDC: 70518-2273-03\n \n                  NDC: 70518-2273-04\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 14 in 1 BLISTER PACK\n                  PACKAGING: 30 in 1 BOTTLE PLASTIC\n                  PACKAGING: 28 in 1 BOTTLE PLASTIC\n                  PACKAGING: 40 in 1 BOTTLE PLASTIC \n                  \n                  \n                  \n                  Store at 20°C to 25°C (68°F to77°F); excursions permitted to 15 to 30°C (59 to 86°F) [see USP Controlled Room Temperature].\n                  \n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Cephalexin is contraindicated in patients with known hypersensitivity to cephalexin or other members of the cephalosporin class of antibacterial drugs."
}